Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
AffaMed Therapeutics logo

AffaMed Therapeutics

Recent Finacing

Series B

Recent Raise

$170M

AffaMed Therapeutics is a clinical-stage biopharmaceutical company developing ophthalmic, neurological, and psychiatric therapies, operating a global development platform focused on clinical development, regulatory affairs, and business development.

Founded 2019
New York, United States
51-100
Private
affamed.com

Highlights

Focus Areas

Biotechnology

Recent Investors

S
Lake Bleu Capital logo
Partners Investment logo
F
CBC Group logo
O

Financials

$170M

Total Raised

1

Funding round

6

Investors


Team

Upgrade to view the team

See the team members at AffaMed Therapeutics.